FilingSEC EDGAR8-K
Endovia Health Sciences Welcomes Federal Cannabinoid Policy Shift and Advances FDA Development
· SEC accepted
StageDevelopment
Filing content
The company welcomed federal support for rescheduling marijuana to Schedule III and plans to request an FDA pre-submission conference for CannEpil® while pursuing additional financing.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…